$COSMJun 26, 2026, 4:30 PMAI processed
COSM signs distribution deal with Qatar's IMC; initial 31,000‑unit order for Sky Premium Life
AI Summary
Cosmos Health (NASDAQ: COSM) signed a distribution agreement with International Medical Company (IMC), owner of Qatar's Kulud Pharmacies, to sell its Sky Premium Life nutraceutical line in Qatar; IMC placed an initial purchase order for 31,000 units and will handle sales, regulatory, logistics and distribution. The deal gives Cosmos immediate retail access across Kulud's >130 pharmacies and supports Sky Premium Life's Gulf expansion, though the company did not disclose pricing, revenue impact or the cadence of follow-on orders.
Positives
- Distribution agreement with IMC/Kulud Pharmacies brings immediate access to a nationwide retail network of 130+ branches
- IMC placed an initial purchase order of 31,000 Sky Premium Life units, indicating immediate commercial demand
- IMC will manage sales, marketing, regulatory, logistics and distribution locally, reducing Cosmos' execution burden
Negatives
- No pricing, revenue estimates or financial terms disclosed for the deal or initial order
- Timing and frequency of future orders or total market impact in Qatar not specified
- Company noted general forward‑looking and regional/geopolitical risks that could affect execution
